PharmacoEconomics

Aims & Scope

PharmacoEconomics is the benchmark journal for peer-reviewed, authoritative and practical articles on the application of pharmacoeconomics and quality-of-life assessment to optimum drug therapy and health outcomes.

An invaluable source of applied pharmacoeconomic original research and educational material for the healthcare decision maker.

PharmacoEconomics is dedicated to the clear communication of complex pharmacoeconomic issues related to patient care and drug utilization.

PharmacoEconomics offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content.

Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership.

Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.6
2024	4.40

SJR (SCImago Journal Rank)

Year	Value
2024	1.880

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	124

Journal Rank

Year	Value
2024	1616

Journal Citation Indicator

Year	Value
2024	1535

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument

  Citation: 2356

  Authors: Margaret C., Arthur S., Ellen M.

• The Epidemiology of Obesity: A Big Picture

  Citation: 2118

  Authors: Adela, Frank B.

• Conducting Discrete Choice Experiments to Inform Healthcare Decision Making

  Citation: 1311

  Authors: Emily, Jordan

• Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?

  Citation: 1148

  Authors: Milad, John

• Determining Clinically Important Differences in Health Status Measures

  Citation: 723

  Authors: Greg, David, Margaret L., G Rhys, Joseph, David

• An Introduction to Markov Modelling for Economic Evaluation

  Citation: 692

  Authors: Andrew, Mark

• The NICE Cost-Effectiveness Threshold

  Citation: 676

  Authors: Christopher, Karl, Anthony J

• Discrete Choice Experiments in Health Economics: A Review of the Literature

  Citation: 652

  Authors: Michael D., Domino, Stavros, Domenico, Esther W.

• The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018)

  Citation: 637

  Authors: Paul E., Andree-Anne, Tammy, Mark, Richard, Sarah H., Ronald C.

• The health economics of bladder cancer

  Citation: 630

  Authors: Marc F., Chris L., Alberto, Benjamin, Robert

---